These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26209775)

  • 1. Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: In vitro and in vivo studies.
    Tseng YY; Wang YC; Su CH; Yang TC; Chang TM; Kau YC; Liu SJ
    Colloids Surf B Biointerfaces; 2015 Oct; 134():254-61. PubMed ID: 26209775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies.
    Tseng YY; Liao JY; Chen WA; Kao YC; Liu SJ
    Expert Opin Drug Deliv; 2013 Jul; 10(7):879-88. PubMed ID: 23289446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.
    Tseng YY; Yang TC; Wang YC; Lee WH; Chang TM; Kau YC; Liu SJ
    Int J Nanomedicine; 2017; 12():1265-1276. PubMed ID: 28243088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
    Tseng YY; Su CH; Yang ST; Huang YC; Lee WH; Wang YC; Liu SC; Liu SJ
    Oncotarget; 2016 Sep; 7(37):59902-59916. PubMed ID: 27494894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.
    Tseng YY; Huang YC; Yang TC; Yang ST; Liu SC; Chang TM; Kau YC; Liu SJ
    Sci Rep; 2016 Jul; 6():30630. PubMed ID: 27471070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Brandes AA; Tosoni A; Basso U; Reni M; Valduga F; Monfardini S; Amistà P; Nicolardi L; Sotti G; Ermani M
    J Clin Oncol; 2004 Dec; 22(23):4779-86. PubMed ID: 15570079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats.
    Liu SJ; Yang TC; Yang ST; Chen YC; Tseng YY
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):515-526. PubMed ID: 29658349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.
    Balaña C; Ramirez JL; Taron M; Roussos Y; Ariza A; Ballester R; Sarries C; Mendez P; Sanchez JJ; Rosell R
    Clin Cancer Res; 2003 Apr; 9(4):1461-8. PubMed ID: 12684420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of diabetic wound repair using biodegradable nanofibrous metformin-eluting membranes: in vitro and in vivo.
    Lee CH; Hsieh MJ; Chang SH; Lin YH; Liu SJ; Lin TY; Hung KC; Pang JH; Juang JH
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):3979-86. PubMed ID: 24568239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies.
    Tseng YY; Kao YC; Liao JY; Chen WA; Liu SJ
    ACS Chem Neurosci; 2013 Sep; 4(9):1314-21. PubMed ID: 23815098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats.
    Emerich DF; Winn SR; Bartus RT
    Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biodegradable sandwich-structured nanofibrous drug-eluting membranes for repair of infected wounds: an in vitro and in vivo study.
    Chen DW; Liao JY; Liu SJ; Chan EC
    Int J Nanomedicine; 2012; 7():763-71. PubMed ID: 22359454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lidocaine/ketorolac-loaded biodegradable nanofibrous anti-adhesive membranes that offer sustained pain relief for surgical wounds.
    Kao CW; Lee D; Wu MH; Chen JK; He HL; Liu SJ
    Int J Nanomedicine; 2017; 12():5893-5901. PubMed ID: 28860755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
    Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
    J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
    Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
    Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
    Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.